Is ultrasound monitoring of the ovaries during ovulation induction by clomiphene citrate essential? A systematic review

Journal of Obstetrics and Gynaecology

Volumn 31, Issue 7, 2011, Pages 566-571

  Galazis, N ^a   Zertalis, M ^a   Haoula, Z ^b   Atiomo, W ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Clomiphene citrate; Ovulation induction; Ovulatory dysfunction; Systematic review; Ultrasound

Indexed keywords

CLOMIFENE CITRATE;

ANOVULATION; CLINICAL TRIAL; DRUG SAFETY; HUMAN; MONITORING; MULTIPLE PREGNANCY; OVARY; OVULATION INDUCTION; PRACTICE GUIDELINE; PREGNANCY RATE; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TRANSVAGINAL ECHOGRAPHY;

CLOMIPHENE; FEMALE; HUMANS; MEDLINE; OVARY; OVULATION INDUCTION; PREGNANCY; PREGNANCY, MULTIPLE; TREATMENT OUTCOME;

EID: 80053644038     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.3109/01443615.2011.596956     Document Type: Review

References (11)

1. Abdul-Kari[n]m RW, Terry FM, Badawy SZ, Sheehe PR. 1990. Effect of ultrasound monitoring of follicular growth on the conception rate. A clinical study. Journal of Reproductive Medicine 35:147-151. (Pubitemid 20075377)
2. Coughlan C, Fitzgerald J, Milne P, Wingfield M. 2010. Is it safe to prescribe clomiphene citrate without ultrasound monitoring facilities? Journal of Obstetrics and Gynaecology 30:393-396.
3. Dickey RP. 2007. The relative contribution of assisted reproductive technologies and ovulation induction to multiple births in the United States 5 years aft er the Society for Assisted Reproductive Technology/American Society for Reproductive Medicine recommendation to limit the number of embryos transferred. Fertility and Sterility 88:1554-1561. (Pubitemid 350253097)
4. Giannopoulos T, Sherriff E, Croucher C. 2005. Follicle tracking of women receiving clomiphene citrate for ovulation induction. Journal of Obstetrics and Gynaecology 25:169-171. (Pubitemid 43323034)
5. Kousta E, White DM, Franks S. 1997. Modern use of clomiphene citrate in induction of ovulation. Human Reproduction Update 3:359-365. (Pubitemid 27515543)
6. Levene MI, Wild J, Steer P. 1992. Higher multiple births and the modern management of infertility in Britain. The British Association of Perinatal Medicine. British Journal of Obstetrics and Gynaecology 99:607-613.
7. NICE. 2004. Clinical Guideline No. 11. Fertility: Assessment and treatment for people with fertility problems. London: National Institute for Clinical Excellence.
8. RCOG. 1998. National evidence-based clinical guidelines. The management of fertility in secondary care. London: Royal College of Obstetricians and Gynaecologists.
9. Smith YR, Randolph JF Jr, Christman GM, Ansbacher R, Howe DM, Hurd WW. 1998. Comparison of low-technology and high-technology monitoring of clomiphene citrate ovulation induction. Fertility and Sterility 70:165-168. (Pubitemid 28294643)
10. Scialli AR. 1986. The reproductive toxicity of ovulation induction. Fertility and Sterility 45:315-323. (Pubitemid 16127153)
11. Zreik TG, García-Velasco JA, Habboosh MS, Olive DL, Arici A. 1999. Prospective, randomized, crossover study to evaluate the benefit of human chorionic gonadotropin-timed versus urinary luteinizing hormone-timed intrauterine inseminations in clomiphene citratestimulated treatment cycles. Fertility and Sterility 71:1070-1074. (Pubitemid 29252498)